Ottimo Pharma, a private biotech company pioneering bifunctional medicines to extend the lives of people living with cancer, on Thursday announced the completion of a Series A financing round of over $140 million. The financing will accelerate the lead asset, Jankistomig, a first-in-class PD1/VEGFR2 bifunctional antibody for multiple solid tumour indications, in both IV and […]
Congratulations to Renée Aguiar-Lucander, who won the prestigious Executive of the Year Award – Commercial Stage Companies at the Scrip Awards 2024 As the awards celebrated their 20th anniversary, Renée came top from a list of finalists representing the very best in the biotech industry. Renée led the company through clinical development of Tarpeyo (budesonide), […]
By Stephen Adams, Optimum Strategic Communications Nature has been an inspiration behind the development of many drugs, starting with the humble aspirin, which was originally derived from willow bark. But what if we could learn the secrets of what gives some people the incredible ability to overcome the most serious diseases? What if we could […]
